Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-07-20FDA Approved: FENOFIBRATE — Original Application (Ajanta Pharma USA Inc.)
The FDA approved Ajanta Pharma USA Inc.'s generic fenofibrate (FENOFIBRATE) under an Original Abbreviated New Drug Application.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Effect of Lipid Modifying Drugs on HDL Function in Patients With Hyperlipidemia [NA]
A completed clinical trial update evaluating the effect of lipid-modifying drugs on HDL function in patients with hyperlipidemia. The study …
-
FDA approval · 2018-07-16FDA Approved: COLESEVELAM HYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc.,USA)
FDA approved an Original Application for Colesevelam Hydrochloride (generic) by Glenmark Pharmaceuticals Inc., USA, marking the approval of …
-
CLINICAL_TRIALS trial_result · 2018-07-13Clinical Trial Update: Effect of Vegetable Oils for Use by the Snack Food Industry on Plasma Lipid Levels and Inflammatory Markers [NA]
A completed Tufts University clinical trial studied the effects of vegetable oils used in snacks on plasma lipid levels and inflammatory mar…
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: Effects on Lipid Metabolism of Olive Extracts Rich in Polyphenols [Phase 2]
Phase 2 trial evaluating the effects of polyphenol-rich olive extract on lipid metabolism in individuals with high cholesterol and metabolic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-07-02FDA Approved: CHOLESTYRAMINE — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved the original application for cholestyramine from Zydus Pharmaceuticals (USA) Inc., establishing a generic version of the bile a…
-
FDA approval · 2018-06-26FDA Approved: FENOFIBRATE — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Fenofibrate's original application from Torrent Pharmaceuticals Limited under ANDA210782, making a generic option available for…
-
CLINICAL_TRIALS research · 2018-06-26Clinical Trial Update: Health Outcomes of Patients With Stable Chronic Disease Managed With a Healthcare Kiosk [NA]
This clinical trial update reports health outcomes for patients with stable chronic diseases managed through a healthcare kiosk. Conditions …
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of the fixed-dose combination Telmisartan/Amlodipine/Rosuvastatin in hypertensiv…
-
FDA approval · 2018-06-18FDA Approved: ATORVASTATIN CALCIUM — Original Application (Rising Pharma Holdings, Inc.)
FDA approved Rising Pharma's generic atorvastatin calcium (original ANDA) for lowering cholesterol and reducing cardiovascular risk.
-
FDA approval · 2018-06-07FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Quallent)
FDA approved a supplemental application for atorvastatin calcium from Quallent, authorizing continued approval of this generic statin produc…
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia [Phase 3]
Phase 3 study CJ-30060 in hypertensive patients with hyperlipidemia has completed its trial, evaluating safety and efficacy.
-
FDA approval · 2018-05-25FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for a fixed-dose combination of amlodipine and atorvastatin (amlodipine bes…
-
CLINICAL_TRIALS research · 2018-05-23Clinical Trial Update: Meta-analysis of the Portfolio Dietary Pattern and Cardiometabolic Risk
A meta-analysis assessing the Portfolio Dietary Pattern and its effect on cardiometabolic risk factors, including cholesterol and lipid prof…
-
FDA approval · 2018-05-21FDA Approved: EZETIMIBE — Supplemental Application (Ascend Laboratories, LLC)
FDA has approved a supplemental application for ezetimibe from Ascend Laboratories, LLC, authorizing continued marketing under the ANDA.
-
FDA approval · 2018-05-18FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for fenofibrate submitted by Lupin Pharmaceuticals, Inc. The notice indicates an updated approval fo…
-
FDA approval · 2018-05-18FDA Approved: FENOFIBRATE — Supplemental Application (Cipla USA Inc.,)
FDA approved a supplemental application for fenofibrate filed by Cipla USA Inc. under ANDA207378.
-
FDA approval · 2018-05-18FDA Approved: FENOFIBRATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for fenofibrate from Amneal Pharmaceuticals NY LLC, approving a generic fenofibrate product.
-
FDA approval · 2018-05-18FDA Approved: LIPOFEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Lipofen (fenofibrate) filed by ANI Pharmaceuticals, Inc.
-
FDA label_change · 2018-05-18FDA Approved: FENOFIBRATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for fenofibrate from Glenmark Pharmaceuticals Inc., USA, resulting in changes to the drug’s labe…
-
FDA approval · 2018-05-18FDA Approved: COLESEVELAM HYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's colesevelam hydrochloride as an original application (ANDA) for lowering LDL cholesterol in adults with primary hype…
-
FDA approval · 2018-05-18FDA Approved: FENOFIBRATE — Supplemental Application (Bostal LLC)
FDA approved a supplemental application for Fenofibrate submitted by Bostal LLC under ANDA 207805. The approval confirms the continued appro…
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Effect of Citrus Bioflavonoids/Vitamin E in Conjunction With Fish Oil Supplementation [NA]
This clinical trial update reports on a completed study evaluating the effects of combining citrus bioflavonoids and vitamin E with fish oil…
-
FDA approval · 2018-05-16FDA Approved: COLESEVELAM HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a generic version of Colesevelam hydrochloride from Amneal Pharmaceuticals of New York LLC for lowering elevated LDL cholestero…
-
CLINICAL_TRIALS research · 2018-05-09Clinical Trial Update: The Effect of n-3 PUFA Plant Oil Intake on Human Metabolism [NA]
This clinical trial update examines the effect of consuming plant-based omega-3 fatty acids (n-3 PUFA) on human metabolism in individuals wi…